Trade FibroGen, Inc - FGEN CFD

Add to favourite

17.79

3.55%

View detailed chart

0.23

Low: 17.36

High: 18.71

Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow
Ownership

Trading Conditions

Spread

0.23

Long position overnight fee

-0.025457%

Short position overnight fee

0.003235%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

20%

Stock exchange

United States of America

Commission on trade

*Information provided by Capital.com

FibroGen Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats

Prev. Close*	17.18
Open*	18.65
1-Year Change*	94.88%
Day's Range*	17.36 - 18.71
52 wk Range	8.67-25.69
Average Volume (10 days)	883.63K
Average Volume (3 months)	18.38M
Market Cap	1.69B
P/E Ratio	-100.00K
Shares Outstanding	97.58M
Revenue	116.07M
EPS	-3.27
Dividend (Yield %)	N/A
Beta	0.79
Next Earnings Date	Aug 7, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Jun 2, 2023	17.79	-0.94	-5.02%	18.73	19.05	17.34
Jun 1, 2023	17.18	0.22	1.30%	16.96	17.59	16.70
May 31, 2023	17.16	0.15	0.88%	17.01	17.61	16.72
May 30, 2023	17.04	0.47	2.84%	16.57	17.33	16.46
May 26, 2023	16.65	0.03	0.18%	16.62	16.80	16.33
May 25, 2023	16.82	0.16	0.96%	16.66	16.91	16.44
May 24, 2023	16.90	-0.05	-0.29%	16.95	17.33	16.51
May 23, 2023	17.27	0.06	0.35%	17.21	18.03	16.99
May 22, 2023	17.16	-0.14	-0.81%	17.30	18.02	16.96
May 19, 2023	17.49	-0.07	-0.40%	17.56	18.07	17.20
May 18, 2023	17.53	0.01	0.06%	17.52	17.89	17.29
May 17, 2023	17.77	0.80	4.71%	16.97	17.86	16.92
May 16, 2023	17.40	0.25	1.46%	17.15	17.51	17.08
May 15, 2023	17.58	0.46	2.69%	17.12	17.91	17.03
May 12, 2023	17.31	-0.11	-0.63%	17.42	17.66	17.09
May 11, 2023	17.48	-0.12	-0.68%	17.60	18.00	17.38
May 10, 2023	17.65	0.25	1.44%	17.40	17.84	17.17
May 9, 2023	17.30	1.25	7.79%	16.05	17.89	15.97
May 8, 2023	17.61	0.58	3.41%	17.03	17.73	16.55
May 5, 2023	17.29	1.14	7.06%	16.15	17.55	15.83

FibroGen, Inc Events

Time (UTC)	Country	Event
Wednesday, June 7, 2023
Time (UTC) 15:00	Country US	Event FibroGen Inc Annual Shareholders Meeting FibroGen Inc Annual Shareholders Meeting Forecast - Previous -
Friday, June 16, 2023
Time (UTC) 15:00	Country US	Event FibroGen Inc Annual Shareholders Meeting FibroGen Inc Annual Shareholders Meeting Forecast - Previous -
Monday, August 7, 2023
Time (UTC) 10:59	Country US	Event Q2 2023 FibroGen Inc Earnings Release Q2 2023 FibroGen Inc Earnings Release Forecast - Previous -
Monday, November 6, 2023
Time (UTC) 10:59	Country US	Event Q3 2023 FibroGen Inc Earnings Release Q3 2023 FibroGen Inc Earnings Release Forecast - Previous -

View all events

Annual
Quarterly

	2022	2021	2020	2019	2018
Total revenue	140.734	235.309	176.319	256.577	212.958
Revenue	140.734	235.309	176.319	256.577	212.958
Total Operating Expense	441.759	523.839	368.199	345.891	299.651
Selling/General/Admin. Expenses, Total	127.474	120.557	97.238	126.557	63.812
Research & Development	296.791	387.043	252.924	209.265	235.839
Operating Income	-301.025	-288.53	-191.88	-89.314	-86.693
Interest Income (Expense), Net Non-Operating	6.156	-2.153	3.151	12.672	0.577
Net Income Before Taxes	-294.869	-290.683	-188.729	-76.642	-86.116
Net Income After Taxes	-295.227	-291.03	-189.089	-76.97	-86.42
Net Income Before Extra. Items	-293.654	-290.023	-189.291	-76.97	-86.42
Net Income	-293.654	-290.023	-189.291	-76.97	-86.42
Income Available to Common Excl. Extra. Items	-293.654	-290.023	-189.291	-76.97	-86.42
Income Available to Common Incl. Extra. Items	-293.654	-290.023	-189.291	-76.97	-86.42
Diluted Net Income	-293.654	-290.023	-189.291	-76.97	-86.42
Diluted Weighted Average Shares	93.582	92.349	89.854	86.633	84.062
Diluted EPS Excluding Extraordinary Items	-3.13793	-3.14051	-2.10665	-0.88846	-1.02805
Diluted Normalized EPS	-3.13793	-3.14051	-2.10665	-0.88846	-1.02805
Total Extraordinary Items
Cost of Revenue, Total	20.28	12.871	8.869	1.147
Gross Profit	120.454	222.438	167.45	255.43
Depreciation / Amortization	0.587	4.639	10.369	10.307
Other Operating Expenses, Total	-3.373	-1.271	-1.201	-1.385
Equity In Affiliates	1.573	1.007	-0.202

	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Total revenue	36.161	34.367	15.735	29.806	60.827
Revenue	36.161	34.367	15.735	29.806	60.827
Cost of Revenue, Total	3.491	4.925	4.308	6.809	4.238
Gross Profit	32.67	29.442	11.427	22.997	56.589
Total Operating Expense	112.252	100.519	109.392	108.03	123.82
Selling/General/Admin. Expenses, Total	34.275	33.966	29.902	30.258	30.564
Research & Development	74.486	61.628	75.182	70.963	89.018
Other Operating Expenses, Total
Operating Income	-76.091	-66.152	-93.657	-78.224	-62.993
Interest Income (Expense), Net Non-Operating	-1.336	-0.195	1.714	5.058	-0.419
Net Income Before Taxes	-77.427	-66.347	-91.943	-73.166	-63.412
Net Income After Taxes	-77.501	-66.455	-92.057	-73.189	-63.525
Equity In Affiliates	0.796	0.28	0.407	0.565	0.32
Net Income Before Extra. Items	-76.705	-66.175	-91.65	-72.624	-63.205
Net Income	-76.705	-66.175	-91.65	-72.624	-63.205
Income Available to Common Excl. Extra. Items	-76.705	-66.175	-91.65	-72.624	-63.205
Income Available to Common Incl. Extra. Items	-76.705	-66.175	-91.65	-72.624	-63.205
Diluted Net Income	-76.705	-66.175	-91.65	-72.624	-63.205
Diluted Weighted Average Shares	94.691	94.035	93.767	93.475	93.043
Diluted EPS Excluding Extraordinary Items	-0.81006	-0.70373	-0.97742	-0.77694	-0.67931
Dividends per Share - Common Stock Primary Issue	0		0	0	0
Diluted Normalized EPS	-0.81006	-0.70373	-0.97742	-0.77694	-0.67931

Annual
Quarterly

	2022	2021	2020	2019	2018
Total Current Assets	492.826	474.059	755.11	702.49	690.015
Cash and Short Term Investments	422.008	405.19	686.537	533.757	621.402
Cash	135.819	111.422	88.046	40.715	38.783
Cash & Equivalents	19.881	59.801	590.347	85.551	50.475
Short Term Investments	266.308	233.967	8.144	407.491	532.144
Total Receivables, Net	16.299	25.401	41.883	153.665	63.684
Accounts Receivable - Trade, Net	28.387	36.331	46.01	158.51	16.474
Prepaid Expenses	9.73	7.383	8.353	6.464	4.929
Total Assets	610.087	773.821	826.84	857.397	880.598
Property/Plant/Equipment, Total - Net	100.933	120.15	65.296	84.276	127.198
Property/Plant/Equipment, Total - Gross	253.644	252.362	199.305	195.752	192.397
Accumulated Depreciation, Total	-152.711	-132.212	-134.009	-111.476	-65.199
Long Term Investments	9.409	171.621	2.972	61.118	55.82
Other Long Term Assets, Total	6.919	7.991	3.462	9.513	7.565
Total Current Liabilities	273.562	225.497	163.187	102.745	89.033
Accounts Payable	30.758	26.097	24.789	6.088	9.139
Accrued Expenses	229.639	180.356	104.384	83.816	66.123
Notes Payable/Short Term Debt	0	0	0	0	0
Other Current Liabilities, Total	13.129	19.033	21.684	0.49	13.771
Total Liabilities	631.534	564.675	404.662	341.262	371.399
Total Long Term Debt	17.054	17.616	44.088	55.531	113.955
Long Term Debt	16.917	17.613	18.697	16.78	16.798
Capital Lease Obligations	0.137	0.003	25.391	38.751	97.157
Minority Interest	19.967	19.967	19.271	19.271	19.271
Other Liabilities, Total	320.951	292.403	169.441	163.715	149.14
Total Equity	-21.447	209.146	422.178	516.135	509.199
Redeemable Preferred Stock	0	0	0	0	0
Common Stock	0.942	0.929	0.914	0.877	0.854
Additional Paid-In Capital	1541.02	1476.41	1399.77	1300.72	1226.45
Retained Earnings (Accumulated Deficit)	-1557.69	-1264.03	-974.011	-784.72	-715.827
Other Equity, Total	-5.72	-4.163	-4.499	-0.747	-2.281
Total Liabilities & Shareholders’ Equity	610.087	773.821	826.84	857.397	880.598
Total Common Shares Outstanding	94.1661	92.881	91.441	87.657	85.432
Total Inventory	40.436	31.015	16.53	6.887
Other Current Assets, Total	4.353	5.07	1.807	1.717
Current Port. of LT Debt/Capital Leases	0.036	0.011	12.33	12.351
Deferred Income Tax		9.192	8.675

	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Total Current Assets	430.549	492.826	474.224	520.643	524.415
Cash and Short Term Investments	355.949	422.008	408.52	438.133	428.075
Cash	145.81	135.819	104.509	128.152	165.436
Cash & Equivalents	42.74	19.881	51.451	39.606	20.46
Short Term Investments	167.399	266.308	252.56	270.375	242.179
Total Receivables, Net	17.654	16.299	15.328	33.573	43.883
Accounts Receivable - Trade, Net	29.217	28.387	29.665	60.352	82.638
Total Inventory	42.456	40.436	39.95	40.899	43.067
Prepaid Expenses	14.49	9.73	10.426	8.038	9.39
Other Current Assets, Total		4.353
Total Assets	538.544	610.087	608.837	686.789	745.934
Property/Plant/Equipment, Total - Net	95.367	100.933	105.19	109.159	114.871
Property/Plant/Equipment, Total - Gross		253.644
Accumulated Depreciation, Total		-152.711
Long Term Investments	5.884	9.409	22.411	50.414	97.643
Other Long Term Assets, Total	6.744	6.919	7.012	6.573	9.005
Total Current Liabilities	254.746	273.562	251.994	240.34	255.374
Accounts Payable	71.282	30.758	19.323	29.36	36.353
Accrued Expenses	166.969	229.639	224.577	202.681	211.518
Notes Payable/Short Term Debt	0	0	0	0	0
Current Port. of LT Debt/Capital Leases		0.036
Other Current Liabilities, Total	16.495	13.129	8.094	8.299	7.503
Total Liabilities	587.396	631.534	582.531	583.009	587.886
Total Long Term Debt	17.276	17.054	15.422	16.439	17.374
Long Term Debt	17.276	16.917	15.422	16.439	17.374
Capital Lease Obligations		0.137
Deferred Income Tax
Minority Interest	19.967	19.967	19.967	19.967	19.967
Other Liabilities, Total	295.407	320.951	295.148	306.263	295.171
Total Equity	-48.852	-21.447	26.306	103.78	158.048
Redeemable Preferred Stock	0	0		0	0
Common Stock	0.966	0.942	0.939	0.937	0.933
Additional Paid-In Capital	1589.15	1541.02	1524.23	1509.64	1490.86
Retained Earnings (Accumulated Deficit)	-1634.39	-1557.69	-1491.51	-1399.86	-1327.24
Other Equity, Total	-4.57	-5.72	-7.346	-6.93	-6.505
Total Liabilities & Shareholders’ Equity	538.544	610.087	608.837	686.789	745.934
Total Common Shares Outstanding	96.623	94.1661	93.936	93.733	93.289

Annual
Quarterly

	2022	2021	2020	2019	2018
Net income/Starting Line	-293.654	-290.023	-189.291	-76.97	-86.42
Cash From Operating Activities	-145.933	-82.232	81.602	-78.705	-76.144
Cash From Operating Activities	10.604	14.809	22.047	21.454	6.562
Non-Cash Items	66.687	132.899	74.216	62.47	52.112
Cash Interest Paid	0.104	0.094	0.135	0.174	0.218
Changes in Working Capital	70.43	60.083	174.63	-85.659	-48.398
Cash From Investing Activities	89.116	-426.972	452.487	120.018	-522.123
Capital Expenditures	-38.741	-30.186	-3.994	-5.762	-8.02
Other Investing Cash Flow Items, Total	127.857	-396.786	456.481	125.78	-514.103
Cash From Financing Activities	46.776	-0.563	13.343	-4.3	13.875
Financing Cash Flow Items	-6.62	-7.372	-11.463	-12.75	-15.612
Issuance (Retirement) of Stock, Net	53.934	12.701	37.829	20.778	29.847
Issuance (Retirement) of Debt, Net	-0.538	-5.892	-13.023	-12.328	-0.36
Foreign Exchange Effects	-5.482	2.597	4.695	-0.005	-0.008
Net Change in Cash	-15.523	-507.17	552.127	37.008	-584.4

	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Net income/Starting Line	-76.705	-293.654	-227.479	-135.829	-63.205
Cash From Operating Activities	-101.591	-145.933	-93.42	-41.54	-8.476
Cash From Operating Activities	2.965	10.604	7.914	5.235	2.584
Non-Cash Items	18.148	66.687	49.928	34.441	17.77
Changes in Working Capital	-45.999	70.43	76.217	54.613	34.375
Cash From Investing Activities	103.482	89.116	88.023	43.24	25.935
Capital Expenditures	-0.591	-38.741	-38.408	-37.543	-36.638
Other Investing Cash Flow Items, Total	104.073	127.857	126.431	80.783	62.573
Cash From Financing Activities	31.485	46.776	-1.898	-0.806	-2.893
Financing Cash Flow Items	0	-6.62	-4.562	-3.361	-2.974
Issuance (Retirement) of Stock, Net	31.657	53.934	2.989	2.779	0.183
Issuance (Retirement) of Debt, Net	-0.172	-0.538	-0.325	-0.224	-0.102
Foreign Exchange Effects	-0.526	-5.482	-7.968	-4.359	0.107
Net Change in Cash	32.85	-15.523	-15.263	-3.465	14.673

Investor Name	Investor Type	Percent Outstanding	Shares Held	Shares change	Holdings Date	Turnover Rating
PRIMECAP Management Company	Investment Advisor	14.4767	14126697	231619	2023-03-31	LOW
The Vanguard Group, Inc.	Investment Advisor/Hedge Fund	9.0286	8810326	-613439	2023-03-31	LOW
BlackRock Institutional Trust Company, N.A.	Investment Advisor	6.2737	6122003	89685	2023-03-31	LOW
Astellas Pharma Inc	Corporation	5.0915	4968367	0	2023-01-31	LOW
State Street Global Advisors (US)	Investment Advisor/Hedge Fund	4.1772	4076167	-188810	2023-03-31	LOW
Point72 Asset Management, L.P.	Hedge Fund	3.5113	3426427	-1355218	2023-03-31	HIGH
First Trust Advisors L.P.	Investment Advisor	2.7884	2720975	-254678	2023-03-31	LOW
Baker Bros. Advisors LP	Hedge Fund	2.7027	2637384	1262173	2023-03-31	LOW
Armistice Capital LLC	Hedge Fund	2.3693	2312000	-1552000	2023-03-31	HIGH
Geode Capital Management, L.L.C.	Investment Advisor/Hedge Fund	1.7703	1727545	70450	2023-03-31	LOW
Two Sigma Investments, LP	Hedge Fund	1.7676	1724909	512435	2023-03-31	HIGH
Schroder Investment Management North America Inc.	Investment Advisor	1.5138	1477161	-246616	2023-03-31	LOW
Artisan Partners Limited Partnership	Investment Advisor	1.3847	1351230	1351230	2023-03-31	LOW
Assenagon Asset Management S.A.	Investment Advisor	1.3779	1344583	1344583	2023-03-31	HIGH
Jacobs Levy Equity Management, Inc.	Investment Advisor/Hedge Fund	1.1877	1159027	-348288	2023-03-31	MED
Pictet Asset Management Ltd.	Investment Advisor/Hedge Fund	1.1157	1088768	593915	2023-03-31	LOW
Eventide Asset Management, LLC	Investment Advisor	0.9838	960000	960000	2023-03-31	MED
Nuveen LLC	Pension Fund	0.9185	896293	328958	2023-03-31	LOW
Adage Capital Management, L.P.	Hedge Fund	0.8711	850000	-1800000	2023-03-31	LOW
Eagle Asset Management, Inc.	Investment Advisor/Hedge Fund	0.8488	828307	-74825	2023-03-31	LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group

535K+

Traders

87K+

Active clients monthly

$113M+

Monthly investing volume

$64M+

Withdrawn each month

Try now

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

FibroGen, Inc Company profile

About FibroGen Inc

FibroGen, Inc. is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing a pipeline of first-in-class therapeutics. The Company applies its capabilities in hypoxia-inducible factor (HIF) biology, 2-oxoglutarate enzymology, and connective tissue growth factor (CTGF) biology to advance medicines for the treatment of anemia, fibrotic disease, and cancer. The Company’s product Roxadustat is an oral small molecule inhibitor of HIF-prolyl hydroxylase (HIF-PH) activity for the treatment of anemia caused by chronic kidney disease (CKD). It is also developing Roxadustat for anemia associated with myelodysplastic syndromes (MDS). The Company is also developing Roxadustat for the treatment of chemotherapy-induced anemia (CIA). Pamrevlumab, an anti-CTGF human monoclonal antibody for the treatment of idiopathic pulmonary fibrosis (IPF), locally advanced unresectable pancreatic cancer (LAPC), and Duchenne muscular dystrophy (DMD).

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, FibroGen Inc revenues increased 33% to $235.3M. Net loss increased 53% to $290M. Revenues reflect Europe segment increase of 95% to $131.2M. Higher net loss reflects Research and Development -Balancing increase of 68% to $346.5M (expense), General and Administrative -Balancing increase of 27% to $89.9M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$2.11 to -$3.14.

Industry:

Biotechnology & Medical Research (NEC)

409 Illinois Street
SAN FRANCISCO
CALIFORNIA 94158
US

Income Statement

Annual
Quarterly

News

Turkish lira on top of USA national currency, top view of mixed American dollars banknotes. TRY and USA paper money. Lira and US dollars exchange rate

USD/TRY forecast: Turkish lira under pressure from high inflation and low rates

We look at some of the latest USD/TRY predictions as the Turkish lira hits record lows.

17:07, 1 June 2023

Nvidia’s 5-year stock forecast: Will the chipmaker remain at record highs?

Nvidia has been the winner of the AI race, being the first chip-maker to hit a $1tn market cap. Will the growth continue?

07:46, 31 May 2023

Alphabet Inc and Google logos on a smartphone screen

Google stock forecast 2023-2025

What is the outlook for the tech giant, following a tumultuous 2022?

18:02, 30 May 2023

USD forecast: DXY slides in risk-off market sentiment

The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.

16:10, 24 May 2023

Oil wells pictured in an oil field, silhouetted against clouds

Oil price forecast: Will WTI and Brent regain momentum in 2023?

Discover the drivers behind Brent and WTI volatility and get insights from analyst predictions.

11:38, 22 May 2023

businessman using a mobile phone to check stock market data

Weekly Roundup: Tech stocks lead the way

US stocks push higher as risk appetite surges despite the uncertainty

13:39, 19 May 2023

USD/JPY continues to build higher towards 138

USD/JPY advances towards the top of its ascending triangle as the US dollar moves higher

11:50, 17 May 2023

People also watch

XRP/USD

0.52 Price

-0.750% 1D Chg, %

Trade Now

Oil - Crude

71.98 Price

+2.450% 1D Chg, %

Trade Now

US100

14,557.80 Price

+0.640% 1D Chg, %

Trade Now

Gold

1,948.36 Price

-1.480% 1D Chg, %

Trade Now

Still looking for a broker you can trust?

Join the 535.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading

Long position overnight fee	-0.0753%
Short position overnight fee	0.0069%
Overnight fee time	21:00 (UTC)
Spread	0.00446

Long position overnight fee	-0.0201%
Short position overnight fee	-0.0018%
Overnight fee time	21:00 (UTC)
Spread	0.04

Long position overnight fee	-0.0255%
Short position overnight fee	0.0032%
Overnight fee time	21:00 (UTC)
Spread	3.0

Long position overnight fee	-0.0185%
Short position overnight fee	0.0103%
Overnight fee time	21:00 (UTC)
Spread	0.30